These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 17023156

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.
    Keilholz U, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, Thomas J, Proebstle TM, Schmittel A, Schadendorf D, Velu T, Negrier S, Kleeberg U, Lehman F, Suciu S, Eggermont AM.
    J Clin Oncol; 2005 Sep 20; 23(27):6747-55. PubMed ID: 16170182
    [Abstract] [Full Text] [Related]

  • 3. Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma.
    Bar J, Yerushalmi R, Shapira-Frummer R, Kutchuk I, Sulkes A, Gutman H, Catane R, Schachter J.
    Oncol Rep; 2008 Dec 20; 20(6):1533-8. PubMed ID: 19020738
    [Abstract] [Full Text] [Related]

  • 4. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA, Gold PJ, Fefer A.
    Semin Oncol; 1997 Feb 20; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
    Richards JM, Mehta N, Ramming K, Skosey P.
    J Clin Oncol; 1992 Aug 20; 10(8):1338-43. PubMed ID: 1634924
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
    Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Seipp CA, Einhorn JH, White DE, Steinberg SM.
    J Clin Oncol; 1999 Mar 20; 17(3):968-75. PubMed ID: 10071291
    [Abstract] [Full Text] [Related]

  • 8. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J, Lopez Hänninen E, Kirchner H, Franzke A, Körfer A, Volkenandt M, Duensing S, Schomburg A, Chaitchik S, Poliwoda H.
    Eur J Cancer; 1995 Jun 20; 31A(6):876-81. PubMed ID: 7646914
    [Abstract] [Full Text] [Related]

  • 9. Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.
    Thompson JA, Gold PJ, Markowitz DR, Byrd DR, Lindgren CG, Fefer A.
    Cancer J Sci Am; 1997 Dec 20; 3 Suppl 1():S29-34. PubMed ID: 9457390
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial.
    Ridolfi R, Chiarion-Sileni V, Guida M, Romanini A, Labianca R, Freschi A, Lo Re G, Nortilli R, Brugnara S, Vitali P, Nanni O, Italian Melanoma Intergroup.
    J Clin Oncol; 2002 Mar 15; 20(6):1600-7. PubMed ID: 11896110
    [Abstract] [Full Text] [Related]

  • 11. Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma.
    Recchia F, Candeloro G, Necozione S, Fumagalli L, Bratta M, Rea S.
    Anticancer Drugs; 2008 Feb 15; 19(2):201-7. PubMed ID: 18176117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined chemoimmunotherapy of metastatic melanoma: a single institution experience.
    Di Lauro V, Scalone S, La Mura N, Zanetti M, Nigri P, Freschi A, Veronesi A.
    Melanoma Res; 2005 Jun 15; 15(3):209-12. PubMed ID: 15917704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study.
    Dorval T, Négrier S, Chevreau C, Avril MF, Baume D, Cupissol D, Oskam R, de Peuter R, Vinke J, Herrera A, Escudier B.
    Cancer; 1999 Mar 01; 85(5):1060-6. PubMed ID: 10091789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.